Recurrent invasive lobular carcinoma presenting as a ruptured breast implant

Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.10.3322/caac.20073Search in Google Scholar

Toikkanen S, Pylkkänen L, Joensuu H. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer 1997; 76: 1234-40.10.1038/bjc.1997.540Search in Google Scholar

Harake MD, Maxwell AJ, Sukumar SA. Primary and metastatic lobular carcinoma of the breast. Clin Radiol 2001; 56: 621-30.10.1053/crad.2001.0766Search in Google Scholar

Winchester DJ, Chang HR, Graves TA, Menck HR, Bland KI, Winchester DP. A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment and outcomes. J Am Coll Surg 1998; 186: 416-22.10.1016/S1072-7515(98)00051-9Search in Google Scholar

Ulukaya E, Karaagac E, Ari F, Oral AY, Adim SB, Tokullugil AH, et al. Chemotherapy increases caspase-cleaved cytokeratin 18 in the serum of breast cancer patients. Radiol Oncol 2011; 45: 116-22.10.2478/v10019-011-0006-7Search in Google Scholar

Plesnicar A, Golicnik M, Fazarinc IK, Kralj B, Kovac V, Plesnicar BK. Attitudes of midwifery students towards teaching breast-self examination. Radiol Oncol 2010; 44: 52-6.10.2478/v10019-010-0009-9Search in Google Scholar

Pestalozzi B. Portrait of invasive lobular carcinoma of the breast. Eur J Cancer 2009; 45(Suppl 1): 450-1.10.1016/S0959-8049(09)70085-1Search in Google Scholar

Hussien MI, Anwar IF, Down SK, Rizvi S, Farooq N, Burger A, et al. Invasive lobular carcinoma of the breast: should this be regarded as a chronic disease? Int J Surg 2010; 8: 346-52.10.1016/j.ijsu.2010.04.003Search in Google Scholar

Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004; 6: 149-56.10.1186/bcr767Search in Google Scholar

Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, et al. Infiltrating lobular carcinoma of the breast: clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996; 77: 113-20.10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8Search in Google Scholar

Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, Gelber RD, et al. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 international breast cancer study group clinical trials. J Clin Oncol 2008; 26: 3006-14.10.1200/JCO.2007.14.9336Search in Google Scholar

Dian D, Herold H, Mylonas I, Scholz C, Janni W, Sommer H, et al. Survival analysis between patients with invasive ductal and invasive lobular breast cancer. Arch Gynecol Obstet 2009; 279: 23-8.10.1007/s00404-008-0662-zSearch in Google Scholar

Harris M, Howell A, Chrissohou M, Swindell RIC, Hudson M, Sellwood RA. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer 1984; 50: 23-30.10.1038/bjc.1984.135Search in Google Scholar

Borst MJ, Ingold JA. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 1993; 114: 637-42.Search in Google Scholar

Lamovec J, Bracko M. Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study. J Surg Oncol 1991; 48: 28-33.10.1002/jso.2930480106Search in Google Scholar

Harris EER, Santiago RJ, Qin L, Hwang WT, Solin LJ. Similar long-term results of breast-conservation treatment for stage i and ii invasive lobular carcinoma compared with invasive ductal carcinoma of the breast. Cancer 2005; 103: 2447-54.10.1002/cncr.21071Search in Google Scholar

Singletary SE, Patel-Parekh L, Bland KI. Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann Surg 2005; 242: 281-9.10.1097/01.sla.0000171306.74366.22Search in Google Scholar

Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 2000; 18: 2817-27.10.1200/JCO.2000.18.15.2817Search in Google Scholar

Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82C randomized trial. Lancet 1999; 353: 1641-8.10.1016/S0140-6736(98)09201-0Search in Google Scholar

Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956-62.10.1056/NEJM1997100233714029309100Search in Google Scholar

Recht A, Gray R, Davidson NE, Fowble BL, Solin LJ, Cummings FJ, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 1999; 17: 1689-700.10.1200/JCO.1999.17.6.168910561205Search in Google Scholar

Willner J, Kiricuta IC, Kölbl O. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? results of univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 1997; 37: 853-63.10.1016/S0360-3016(96)00556-1Search in Google Scholar

de Camara DL, Sheridan JM, Kammer BA. Rupture and aging of silicone gel breast implants. Plast Reconstr Surg 1993; 91: 828-34.10.1097/00006534-199304001-00012Search in Google Scholar

Robinson OG Jr, Bradley EL, Wilson DS. Analysis of explanted silicone implants: a report of 300 patients. Ann Plast Surg 1995; 34: 1-6.10.1097/00000637-199501000-00001Search in Google Scholar

Brinton LA, Brown SL. Breast implants and cancer. J Natl Cancer Inst 1997; 89: 1341-9.10.1093/jnci/89.18.1341Search in Google Scholar

Silverstein MJ, Handel N, Gamagami P, Gierson ED, Furmanski M, Collins AR, et al. Breast cancer diagnosis and prognosis in women following augmentation with silicone gel-filled prostheses. Eur J Cancer 1992; 28: 635-640.10.1016/S0959-8049(05)80115-7Search in Google Scholar

Leibman AJ, Kruse B. Breast cancer: mammographic and sonographic findings after augmentation mammoplasty. Radiology 1990; 174: 195-8.10.1148/radiology.174.1.21529812152981Search in Google Scholar

Brody GS, Deapen DM. Breast cancer diagnosis is the augmented patient [letter]. Arch Surg 1989; 124: 256-8.10.1001/archsurg.1989.014100201300242916948Search in Google Scholar

Deapen DM, Bernstein L, Brody GS. Are breast implants anticarcinogenic? A 14-year follow-up of the Los Angeles Study. Plast Reconstr Surg 1997; 99: 1346-53.10.1097/00006534-199705000-00022Search in Google Scholar

Birdsell DC, Jenkins H, Berkel H. Breast cancer diagnosis and survival in women with and without breast implants. Plast Reconstr Surg 1993; 92: 795-800.10.1097/00006534-199392050-00003Search in Google Scholar

Petit JY, Le MG, Mouriesse H, Rietjens M, Gill P, Contesso G, et al. Can breast reconstruction with gel-filled silicone implants increase the risk of death and second primary cancer in patients treated by mastecomty for breast cancer? Plast Reconstr Surg 1994; 94: 115-9.10.1097/00006534-199407000-000118016223Search in Google Scholar

Mátrai Z, Tóth L, Gulyás G, Szabó E, Szentirmay Z, Kásler M. A desmoid tumor associated with a ruptured silicone breast implant. Plast Reconstr Surg 2011; 127: 1e-4e.10.1097/PRS.0b013e3181f958ba21200191Search in Google Scholar